Business Wire | May 26, 2021 05:00PM EDT

Eagle Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021

May 26, 2021

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--May 26, 2021--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ("Eagle" or the "Company") today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:

Date: Wednesday, June 2, 2021

Time: 1:30 p.m. Eastern Time

Webcast: https://wsw.com/webcast/jeff174/egrx/1863162

The presentations will be webcast live at the aforementioned times, and archived for 30 days thereafter, via the Company's website at www.eagleus.com, under the Investors section.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients' lives. Eagle's commercialized products include RYANODEX(r), BENDEKA(r), BELRAPZO(r), and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle's website at www.eagleus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210526006111/en/

CONTACT: Investor Relations for Eagle Pharmaceuticals, Inc.: Lisa M. Wilson In-Site Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com